Sharing the benefits of genetic research

At the sixth World Trade Organization ministerial conference in Hong Kong, one issue with implications for the development of medical products is the tension between international patenting laws and benefit sharing requirements, which may threaten agreements on protecting biodiversity. The World Trade Organization can stop the exploitation of non-human genetic material and traditional knowledge by aligning the trade related intellectual property rights (TRIPS) agreement with the Convention on Biological Diversity.